Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KY › Salyersville › NPI 1447683958
Physician

Highlands Hospital Corp

Highlands Hospital Corp was paid $580K by Medicaid between Jan 2018 and Jan 2020, across 37 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 65% of everything it billed.

33Billing provider infoHIGHLANDS HOSPITAL CORP
SALYERSVILLE, KY 41465
33aNPI1447683958assigned 08/20/2013
28Total paid$580K
24GClaims23,848
24DCodes billed37
24AFirst – last monthJan 2018 – Jan 2020
Compared with peers

Next to other Family Medicine Physician providers in Kentucky

Rank by total paid#88 of 352
Median peer was paid$90K
This provider vs. median6.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201813,839$320K
20199,734$254K
2020275$6K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 65% 10,652 5,792 $375K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 17% 2,229 1,964 $97K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 6.2% 709 284 $36K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 3.3% 1,428 647 $19K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2.8% 697 653 $16K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2.4% 1,091 992 $14K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.2% 429 387 $7K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 303 296 $5K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity <1% 55 54 $4K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 45 45 $3K
36415 Collection of venous blood by venipuncture <1% 200 169 $1K
96127 <1% 335 301 $1K
25 more codes
90686 <1% 35 $633.56
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 39 $591.12
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 132 $168.57
G8431 Screening for depression is documented as being positive and a follow-up plan is documented <1% 412 $0.45
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications <1% 1,719 $0.08
G8754 Most recent diastolic blood pressure < 90 mmhg 0% 384 $0.00
G8420 Bmi is documented within normal parameters and no follow-up plan is required 0% 394 $0.00
G9903 Patient screened for tobacco use and identified as a tobacco non-user 0% 28 $0.00
G8950 Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented 0% 479 $0.00
1036F 0% 212 $0.00
3017F 0% 34 $0.00
G9902 Patient screened for tobacco use and identified as a tobacco user 0% 56 $0.00
3014F 0% 13 $0.00
1006F 0% 12 $0.00
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 0% 31 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 0% 14 $0.00
1111F 0% 17 $0.00
4004F 0% 230 $0.00
G8752 Most recent systolic blood pressure < 140 mmhg 0% 267 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 0% 931 $0.00
G8482 Influenza immunization administered or previously received 0% 49 $0.00
G8753 Most recent systolic blood pressure >= 140 mmhg 0% 32 $0.00
G9744 Patient not eligible due to active diagnosis of hypertension 0% 77 $0.00
G0444 Annual depression screening, 5 to 15 minutes 0% 65 $0.00
G8783 Normal blood pressure reading documented, follow-up not required 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWARMAN, HAROLD (CEO)
Same official

Other billing entities under WARMAN, HAROLD

Full network →
ProviderLocationPaid
Highlands Hospital CorpHarold, KY$581K
Highlands Heart and Vascular LLCPrestonsburg, KY$137K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.